Related references
Note: Only part of the references are listed.Substrate-Inspired Fragment Merging and Growing Affords Efficacious LasB Inhibitors
Cansu Kaya et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)
A New PqsR Inverse Agonist Potentiates Tobramycin Efficacy to Eradicate Pseudomonas aeruginosa Biofilms
Christian Schuetz et al.
ADVANCED SCIENCE (2021)
OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space
Chao Lu et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2021)
Inhibition of bacterial and human zinc-metalloproteases by bisphosphonate- and catechol-containing compounds
Fatema Rahman et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
ZN148 Is a Modular Synthetic Metallo-β-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens In Vivo
Orjan Samuelsen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
N-Aryl-3-mercaptosuccinimides as Antivirulence Agents Targeting Pseudomonas aeruginosa Elastase and Clostridium Collagenases
Jelena Konstantinovic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Targeting Metalloenzymes for Therapeutic Intervention
Allie Y. Chen et al.
CHEMICAL REVIEWS (2019)
Synthesis and biological evaluation of new dipicolylamine zinc chelators as metallo-β-lactamase inhibitors
Anthony Prandina et al.
TETRAHEDRON (2019)
Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases
Gregg B. Fields
FRONTIERS IN IMMUNOLOGY (2019)
The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
Gregg B. Fields
CELLS (2019)
Synthesis and biological evaluation of zinc chelating compounds as metallo-β-lactamase inhibitors
Geir Kildahl-Andersen et al.
MEDCHEMCOMM (2019)
The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database
Neil D. Rawlings et al.
NUCLEIC ACIDS RESEARCH (2018)
Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes
Arthur Winer et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors
Christian Schnaars et al.
ACS INFECTIOUS DISEASES (2018)
Tackling Pseudomonas aeruginosa Virulence by a Hydroxamic Acid-Based LasB Inhibitor
Andreas M. Kany et al.
ACS CHEMICAL BIOLOGY (2018)
The selectivity of galardin and an azasugar-based hydroxamate compound for human matrix metalloproteases and bacterial metalloproteases
Ingebrigt Sylte et al.
PLOS ONE (2018)
Bacterial proteases, untapped antimicrobial drug targets
Elizabeth Culp et al.
JOURNAL OF ANTIBIOTICS (2017)
Zinc-Metalloproteinase Inhibitors: Evaluation of the Complex Role Played by the Zinc-Binding Group on Potency and Selectivity
Cecile Rouanet-Mehouas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Intramembrane proteases as drug targets
Steven H. L. Verhelst
FEBS JOURNAL (2017)
Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Seth W. Dickey et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Pharmacological Targeting of the Host-Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs
Jason Munguia et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Inhibitors of metallo-β-lactamases
Caitlyn M. Rotondo et al.
CURRENT OPINION IN MICROBIOLOGY (2017)
MMP Inhibitors: Past, present and future
Jillian M. Cathcart et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2015)
New roles for mitochondrial proteases in health, ageing and disease
Pedro M. Quiros et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
PAC-1 and isatin derivatives are weak matrix metalloproteinase inhibitors
Stian Sjoli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance
Andrew M. King et al.
NATURE (2014)
Is there new hope for therapeutic matrix metalloproteinase inhibition?
Roosmarijn E. Vandenbroucke et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Architecture and function of metallopeptidase catalytic domains
Nuria Cerda-Costa et al.
PROTEIN SCIENCE (2014)
MMPs in the Neuroretina and Optic Nerve: Modulators of Glaucoma Pathogenesis and Repair?
Lies De Groef et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Metallo-beta-lactamase structure and function
Timothy Palzkill
ANTIMICROBIAL THERAPEUTICS REVIEWS: THE BACTERIAL CELL WALL AS AN ANTIMICROBIAL TARGET (2013)
Pouring Salt on a Wound: Pseudomonas aeruginosa Virulence Factors Alter Na+ and Cl- Flux in the Lung
Alicia E. Ballok et al.
JOURNAL OF BACTERIOLOGY (2013)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
A standard orientation for metallopeptidases
F. Xavier Gomis-Rueth et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2012)
Tissue factor and factor VIIa - Hemostasis and beyond
Alisa S. Wolberg et al.
THROMBOSIS RESEARCH (2012)
Regulation of matrix metalloproteinase activity in health and disease
Elin Hadler-Olsen et al.
FEBS JOURNAL (2011)
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Chrisostomi Gialeli et al.
FEBS JOURNAL (2011)
MECHANISMS OF DISEASE Proprotein Convertases in Health and Disease
Andrew W. Artenstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Thermolysin Family (M4) of Enzymes: Therapeutic and Biotechnological Potential
Olayiwola A. Adekoya et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
Specific targeting of metzincin family members with small-molecule inhibitors: Progress toward a multifarious challenge
Dimitris Georgiadis et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Proteases: Multifunctional Enzymes in Life and Disease
Carlos Lopez-Otin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
MMPs as therapeutic targets - Still a viable option?
Barbara Fingleton
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
The coordination chemistry of tripodal tetraamine ligands
AG Blackman
POLYHEDRON (2005)
Share Paper
